I Simposio Internacional en Enfermedades Infecciosas en Pacientes Inmunocomprometidos

Pedro Puerta Alcalde, specialist in Internal Medicine, trained at Bellvitge University Hospital. He obtained his PhD in 2020 from the University of Barcelona. He worked as an infectious disease specialist at Hospital Clínic of Barcelona between 2017 and 2024. He is currently co-head of the Immunocompromised Patients Section at Germans Trias i Pujol Hospital in Badalona. Member of the Board of Directors of the Spanish Group of Medical Mycology (SEIMC). Expert in fungal infections and multidrug-resistant organisms.

Dr. Adaia Albasanz Puig is a faculty member in the Infectious Diseases Department at Vall d’Hebron University Hospital in Barcelona, Spain. Her clinical work focuses on the management of infectious complications in immunocompromised patients. She is currently responsible for the Infectious Diseases program in oncohematology at Vall d’Hebron University Hospital.

Her research initially focused on optimizing the management of bacterial infections in patients with febrile neutropenia. Her current academic work focuses on infectious complications in patients with hematological malignancies, particularly invasive fungal diseases and infections associated with T-cell–redirecting therapies.

She is a member of the Vall d’Hebron Infectious Diseases Research Group and collaborates with the Vall d’Hebron Institute of Oncology. She is also a member of the Spanish Group of Medical Mycology and an Associate Professor at the Faculty of Medicine of the Universitat Autònoma de Barcelona.

Dr. Carlota Gudiol is a Consultant in Infectious Diseases at the Infectious Diseases Department of Bellvitge University Hospital in Barcelona. She is also an Associate Professor of Infectious Diseases in the Department of Medicine at the Faculty of Medicine of the University of Barcelona.

MD, University of Navarra (2005)

Roger Paredes, MD, PhD, is the Head of the Infectious Diseases Service at Hospital Universitari Germans Trias i Pujol, Head of the Microbial Genomics Group at the IrsiCaixa AIDS Research Institute, Badalona, Spain.

Roger Paredes obtained an MD, PhD degree in Medicine and Surgery from the Autonomous University of Barcelona (UAB). He specialised in HIV resistance at the Brigham & Women’s Hospital in Boston and Harvard Medical School. His team has demonstrated the clinical utility of HIV-1 deep sequencing in both high- and low-income countries.